Answer extracted from the The Conference Room with Simon Lader podcast — listen to the full episode below.
What is the vision behind the new AI-native health platform Dr. Sherry Zhang is building at Buck Institute?
Rather than asking patients the reactive question "What's wrong with you today?", the platform asks proactive questions like "Where is your health headed?" and forecasts different health futures based on genome, proteomic, microbiome, lifestyle, and environmental data. By comparing individuals to others who share similar genomic and lifestyle profiles, the platform computes personalized trajectories and recommends two to four specific actions to improve health outcomes, moving medicine from reactive treatment to preventive personalization.
From Diagnosis to Prediction
The shift Zhang is driving at Buck Institute for Research on Aging represents a fundamental change in how health platforms engage patients. Instead of waiting for symptoms or disease markers to appear, the AI system uses multi-omic data—genomics, proteomics, and microbiome information—to model future health states before they materialize.
This approach draws on Zhang's earlier work founding Genopalate, the personalized nutrition company that has served more than 170,000 customers by translating genetic data into dietary recommendations. The Buck Institute platform extends that principle across the entire health ecosystem, weaving together not just genetic predisposition but lifestyle choices, environment, and biological markers to create a continuous forecast of where each person's health trajectory is headed.
Personalization Through Comparative Genomics
The engine of the platform is comparative analysis: matching an individual against cohorts of people with similar genetic profiles and environmental exposures. This method allows the system to generate not generic health advice but deeply personalized recommendations based on what actually worked—or failed—for people whose biology most closely resembles the patient's own.
Zhang explains that from this comparative lens, the platform can identify and recommend two to four specific, actionable interventions tailored to each person's unique risk profile and circumstances. This contrasts sharply with one-size-fits-all health messaging or even broad risk categories. The recommendations emerge directly from the data of similar individuals, making them both more credible and more likely to be adopted.
"This drive in me to deliver world-class science and translate that into something useful and practical for everyday people is so strong that I think that will motivate me to learn new skills, to meet new people, to get on stage that I'll be nervous for, and raise funding."
Sherry Zhang — Executive Director of External Strategy and Partnerships at the Price Lab at Buck Institute for Research on Aging. Dr. Zhang is a first-generation immigrant scientist who arrived in the United States from China with three bags and $3,000. She earned her PhD in molecular biology from Marquette University in Wisconsin and conducted obesity genomics research at Medical College of Wisconsin (MCW) under Dr. Ahmed Kaseba, the physician who coined the concept of metabolic syndrome. As founder of Genopalate, she built a personalized nutrition platform serving more than 170,000 customers before bringing her vision for AI-driven preventive health to the aging research community.
The vision extends beyond individual recommendations: this episode of The Conference Room reveals how Zhang is leveraging the Buck Institute's research infrastructure to make longitudinal health forecasting a practical tool for millions, not just the wealthy few who can afford boutique preventive medicine.
See also
How should founders structure internal communication to avoid meeting overload while maintaining alignment?
Dr. Zhang implements a cadenced communication structure: daily standups of 15 minutes for urgent issues and blockers; weekly touchbase meetings to maintain alignment across teams without drowning in meetings.
What is the minimum viable product strategy for early-stage biotech companies?
Founders must listen deeply to their first and second customer personas, then build a product in a lean way by identifying the minimal viable product that solves their core problem without overengineering.
How does leadership differ between academic research, startup founding, and established research institutions?
Scientists are trained to reduce uncertainty through data and hypotheses, while founders must navigate uncertainty as a constant reality. Dr. Zhang combines both frameworks to lead effectively at Buck Institute.